The results of experiments with indirect methods have suggested that various interventions reduce infarct size after coronary artery occlusion. To determine and quantify directly both the short-and long-term effects of several interventions on myocardial salvage without relying on indirect methods, the left coronary artery was occluded in 880 rats; they were then given either no treatment or one of the following interventions: (a) hyaluronidase, an enzyme that hydrolyzes interstitial glycoproteins, 1,500 National Formulary (NF) U/kg i.v. 5 min and 24 h after occlusion; (b) cobra venom factor, a protein that depletes the third component of complement, 20 U/kg i.v. 5 min after occlusion; (c) a glucocorticoid: hydrocortisone, 50 mg/kg i.v. 5 min after occlusion; or the five-fold more potent methylprednisolone (MP): (i) 50 mg/kg i.v. 5 min after occlusion or (ii) 50 mg/kg i.v. 5 min after occlusion followed by 50 mg/kg i.m. 3, 6, and 24 h after occlusion; or (d) reserpine, an agent that depletes the heart of catecholamines, 0.5 mg/kg i.m. once on each of the 3 days before occlusion. The animals were sacrificed either 2 days after occlusion, i.e., at the time of peak necrosis, or after 3 wk, i.e., after the infarct was completely healed. The amount of preserved myocardium was then assessed by two independent techniques: planimetric measurement of serial histologic sections and […] To determine and quantify directly both the shortand long-term effects of several interventions on myocardial salvage without relying on indirect methods, the left coronary artery was occluded in 880 rats; they were then given either no treatment or one of the following interventions: (a) hyaluronidase, an enzyme that hydrolyzes interstitial glycoproteins, 1,500 National Formulary (NF) U/kg i.v. 5 min and 24 h after occlusion; (b) cobra venom factor, a protein that depletes the third component of complement, 20 U/kg i.v. 5 min after occlusion; (c) a glucocorticoid: hydrocortisone, 50 mg/kg i.v. 5 min after occlusion; or the fivefold more potent methylprednisolone (MP): (i) 50 mg/kg i.v. 5 min after occlusion or (ii) 50 mg/kg i.v. 5 min after occlusion followed by 50 mg/kg i.m. 3, 6, and 24 h after occlusion; or (d) reserpine, an agent that depletes the heart of catecholamines, 0.5 mg/kg i.m. once on each of the 3 days before occlusion. The animals were sacrificed either 2 days after occlusion, i.e., at the time of peak necrosis, or after 3 wk, i.e., after the infarct was completely healed. The amount of preserved myocardium was then assessed by two independent techniques: planimetric measurement of serial histologic sections and creatine kinase activity of the whole left ventricle. The amount of normal myocardium preserved at 21 days postocclusion was significantly increased, by 22.3±7.8% (P < 0.025) after the administration of hyaluronidase, by 25.3 ±5.8% (P < 0.005) after cobra venom factor, by 14.5 ±6.9% (P < 0.05) after hydrocortisone, by 20.8±8.2% (P < 0.025) after the single dose of MP, by 20.9±3.9% (P < 0
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INTRODUCTION
The prognosis after acute myocardial infarction depends directly on the quantity of remaining viable, normally functioning myocardium (1, 2) . If myocardial cell death after acute coronary occlusion could be reduced, a greater quantity of viable myocardium would remain and this might be expected to reduce the incidence both of intractable cardiogenic shock and of pulmonary edema; immediate mortality would thereby be reduced and chronic heart failure would be less likely.
Animal experiments have shown that salvage of myocardium acutely jeopardized by ischemia may be feasible. After coronary artery occlusion, the speed at which acutely ischemic cells become irreversibly injured is not uniform and depends on their location as well as on a number of other factors (3) (4) (5) . However, the fate of these cells can be modified, at least in the short term, by various therapeutic interventions, as was shown indirectly by epicardial ST segment (4, 5) and QRS (6) mapping, by the relationship between epicardial ST segment elevation and the creatine kinase (CK)1 content ofthe sibjacent myocarditum (4, 5) , and by serial changes in serum CK activity (7, 8) . These experiments involved the uise of the indirect techniques mentioned above and the examination of the effects of interventions 24 h after the occluision, ' Abbreviations used in this paper: CK The presenit study was designed to ultilze the model of experimental myocardial infarction after coronary artery occluision in the rat, in order to measure (lirectly and compare the effectiveiness of different interventions in preserving acutely jeopardized myocardium at the time of peak necrosis and when healing is complete. Two independent techniques were tised to measure the quantity of viable left venitricular myocardium: total CK activity and quantitative histology of the left ventricle. A preliminary report describing this method has been published (9) .
To achieve these goals four interventions that have previously been shown by indirect techniques to limit myocardial necrosis, hyaluronidase (5, 6, (10) (11) (12) (13) (14) , cobra venom factor (15) , hydrocortisone (16) , and methylprednisolone (17) , and one other (reserpine) thought likely to be favorable because of its catecholaminedepleting action (18) were administered, and their effects on myocardial preservation compared.
METHODS
Male Sprague-Dawley rats (Charles River Breeding Laboratories, Wilmington, Mass.), weighing between 200 and 300 g, were lightly anesthetized with ether, the chest opened in the fifth intercostal space aind, while the heart was briefly everted from the thoracic cavity, the main left coronary artery was ligated 1-2 mm from its origin with a 4-0 suture (9, (19) (20) (21) . The heart was then repositioned, and the muscle aind skin layers closed with a "purse-string" 0 suture. The operative mortality was 21%. With the exception of the reserpine-treated group, all treated rats were given the drtig within 5 In a preliminary study of 79 nontreated rats with coronary artery occlusion sacrificed at regular intervals between 1 and 21 days postocelusion, the necrotic process was found to be at its peak 48 h after the coronary occlusion, and healing was complete 3 wk after the occlusion. In this study, therefore, these two times, i.e. 48 h and 21 days after occlusion, were chosen for study; the rats were reanesthetized with ether and their hearts excised. The success of each coronary artery occlusion was tested by the injection of 1 ml/kg of 10% carbon black (particle size 300 A), either i.v. just before sacrifice or into the left coronary, artery after sacrifice. Those rats in which the entire left ventricular free wall became discolored with carbon were considered to have had nonoccluded coronaries and were considered to be sham-operated animals.
After the hearts were excised, the amount of myocardium preserved was measured directly, in the 48-h rats both by histology and left ventricular CK and in the 21-day rats usually only by histology. Left ventricular CK activity at 21 days after occlusion was studied only in the H-treated rats and their controls. For the histologic study, the hearts were fixed in 10% phosphate-buffered formalin for 24 h and the ventricles were then sectioned into four slices, each 2-to 2.5-mm thick, from apex to base and in a plane parallel to the atrioventricular groove. After dehydration and clearing, all four slices from each heart were embedded. 5-Am thick sections were then cut and mounted on 2 x 2-inch glass slides and stained either by hematoxylin-eosin in the rats sacrificed 48 h after occlusion or by Masson's trichrome method to demonstrate collagen in the rats sacrificed 21 days after occlusion.
To assess changes in the quantity of preserved myocardium at the time of peak necrosis (48 h) and after healing is complete (21 days), the histologic sections of all fotur slices from each occluded or sham-operated heart were projected onto a screen at a 10-fold magnification and the following measurements were made by planimetry (22, 23) : In each heart obtained from rats sacrificed 48 h after coronary occlusion (a) the areas of normal and infarcted left ventricular myocardium, and (b) the lengths of the arcs of the endocardial circumference of the left ventricle underlying both the normal and the infarcted myocardium were determined. From these measurements the percentage, both by area and by circumference, of the left ventricle that remained normal was calculated. In the hearts obtained from rats sacrificed 21 days after coronary occlusion, the total area of preserved normal myocardium in the infarcted hearts was measured and expressed per kilogram of body weight; this amount of preserved myocardium was then expressed as a percentage of the mean of the total area of normal myocardium found in 21-day sham-operated rats. Infarct size, as in the 48-h rats, was calculated as a fraction of' the left ventricular circumference (Fig. 1) . The area percentages represent estimates of the fraction of the volume of' the normal left ventricular nmyocardium that was preserved or infarcted, and the circumference percentages represent the fraction of the surface area of' the normal left ventricle that was preserved or comprised the inf;arct. The variation in the histologic measurements of preserved myocardiunm and infarct size, when performed by the same individual on different days, was <5%. The mathematical justification for using two-dimensional tissue sections to make quantitative estimates of threedimensional structures (stereology) is detailed elsewhere (23) .
The quantity of' salvaged myocardium was expressed as follows: (a) the preserved left ventricular CK activity, expressed as a percentage of the normal left ventricular CK activity; (b) the percentages of the left venitricular endocardial circumferenice underlyinig the preserved and the infarcted myocardiuim, (c) in rats sacrificed 48 coroinary occlusion, the preserved and infarcted left ventricular areas were expressed as percentages of the total left ventricular area; (d) in rats sacrificed 21 days after coronary occlusion, the area of preserved left ventricular myocardium, corrected for rat weight, was expressed as a percentage of the normal left ventricular area in sham-operated rats also corrected for bodly weight.
In hearts destined for enzymatic anialysis, the atria, right ventricle, and great vessels were dissected from the left ventricle, which was then homogeniized to permit measurement of its CK activity by spectrophotometric assay (24) . To permit calculation of the amount of preserved myocardium by the enzymatic method, the minimum CK activity in the center of the infarcted tissue was determined and found to average 2.6±0.4 IU/mg protein. After allowing for this "residual" CK, the percentage of the normal left ventricular mass preserved was calculated, using each operating day's nonitreated and treated sham-operated rats for reference. Thus, for example, with a mean left ventricular CK activity of 12.6 IU/mg of protein in nontreated sham-operated rats and of 7.3 IU/mg protein in a rat with an occluded coronary artery, 42.1% of the left ventricular CK activity in the rat with the occlusion has been lost. Infarct size, corrected for the CK activity of 2.6 IU/mg protein in the infarct center, thus equals 42.1 + (2.6 x 42.1/12.6) = 42.1 + 8.7 = 50.8% of the left ventricle. Thus, by this method of assessment, 100.0 -50.8, i.e., 49.2% of the left ventricle has been spared.
In the CVF-treated rats, venous blood samples were taken at sacrifice from both the control and treated rats for measurement of serum complement by the CH50 inhibition method (25) . Additional venous blood samples from CVFtreated shanm-operated rats were taken from groups of three animals each at half:hourly intervals for 4 h after the administration of the CVF, as well as daily thereafter for 1 wk.
Purification of the CVF. Lyophilized Naja naja venom (Ross Allen's Reptile Institute, Inc., Silver Springs, Fla.) was reconstituted and chromatographed on DEAE-cellulose and Sephadex G-200 (25; Pharmacia Fine Chemicals, Piscataway, N. J.). After dissolving 1 g of venom in 65 ml sodium phosphate buffer, 0.03 M, pH 7.4, at 37°C, the sample was applied to a 2.5 x 40-cm column of equilibrated DEAEcellulose. The nonbound proteins, mostly phospholipase, were washed through at 50 ml/h for 16-18 h. A linear salt gradient to 0.5 M NaCl was then begun, and the anti- Taking the "residual" CK activity in the infarcted tissue into account, the Cl-rats were left with 50% of the normal left ventricular mnocardium. In the rats given H after occlusion (H-rats), CK activity averaged 10.4 +0.4 IU/mg of protein, an activity corresponding to that of 76% of the normal left ventricular myocardiuim. The difference between the H-rats and the Cl-rats, i.e. 76 compared with 50%, indicates that H resulted in a 52% increase in the amount of myocardium preserved compared to that in the Cl-rats (P < 0.001; Table I ). When the amount of myocardium preserved at 48 h after occlusion was assessed histologically, the H-rats had 32% (P < 0.001) more normal myocardium by area and 40%n more by circumference (P < 0.001) thai did the Cl-rats (Table I ).
In the rats sacrificed 21 days after the occlusioll, the amount of nomial left ventricuilar myocardium preserved when assessed histologically by area was 22% (P < 0.025) greater in the H-treated rats than in the Clrats (Table II) . Infarct size, measured by circumiiference, was reduced by an average of 36% (P < 0.01; Table III ). These differences were less striking than in the 48-h groups, a finding confirimied by the CK method which showed that 22 H-rats had 16.6±6.5% more preserved myocardium than did 17 C'-rats (P < 0.025). Cobra vtieotmt factor. CVF reduced the mean CH50 level from 188+9 U (±SEM) to less than 50 U within 30 min of its administration, and this depression of serum complement persisted for 4-5 days. At 48 h after occlusion there was, by the CK method, a 22% (P <0.025) increase in the amount of normal myocardium preserved in the CVF-rats compared with the C2-rats (Table I) . Assessed histologically, CVF also increased the amount of myocardium preserved by 10% (P <0.05) when assessed by area and by 16% Preservation of Ischemic Myocardiumn I P values calculated for the differences between control and experimental groups. § All values are presented as mean± SEM.
(P < 0.05) when assessed by the circumference method (Fig. 2 , Table I ). 21 days postocclusion, the amount of normal left ventricular myocardium preserved, when assessed by area, was 25% (P < 0.01) greater in the CVF-rats than in the C2-rats (Table II) <0.005) in the MP x 4-rats (Table I) . Histologically, the increases in the amount of preserved myocardium at 48 h, compared to that in concurrently studied nontreated controls (C3-, C4-, and C5-rats), were, by area, 15% (P < 0.01) for the HC-rats, 11% (P < 0.05) for the MP x 1-rats, and 5% (NS) for the MP x 4-rats, and, by circumference, 19% (P < 0.025) for the HC-rats, 18% (P < 0.025) for the MP x 1-rats, and 8% (NS) for the MP x 4-rats (Table I ).
In the rats sacrificed 21 days after the occlusion, the preserved left ventricular myocardium, assessed by area, was increased by 15% (P < 0.05) in the HC-rats (Fig. 3) , by 21% (P < 0.025) in the MP x 1-rats, and by 21% (P < 0.001) in the MP x 4-rats (Table II) . However, the fraction of the left ventricular circumference comprising the healed infarct at 21 days was not significantly decreased in the glucocorticoid-treated rats compared to their respective controls (Table III) . Actually, in the MP x 4-rats it was increased by 1% although this difference was not statistically significant. This discrepancy between the effect on area and circumference can be explained by stretching of the infarcted tissue during scar formation. Indeed, the infarct thickness was obviously reduced; at its thinnest point in any of the four sections, the transmural infarct averaged 0.63±0.03 mm in the C5-rats and was significantly reduced in the MP x 4-rats in which it averaged 0.47±0.02 mm (P < 0.001).
Reserpine. When measured by the CK method 48 h postocclusion, pretreatment with R achieved a 22% (P < 0.05) greater than in the C6f-rats (Table II) . Inf:arct size in the R-rats, as determined by circumiiifereniee, was 6% (NS) less than in the C6-rats (Table III) .
All interventtionis. 24 h when it is administered before or up to 6 h after coronary artery occlusion in the dog (10, 13) . It also appears to be beneficial for at least 1 wk in patients with acute myocardial infarction when administered within 8 h of the onset of chest pain (12) . The mechanism by which this agent protects the acutely ischemic heart is uncertain. It is known to hydrolyze interstitial glycoproteins and it may therefore improve the transport of nutrients to the ischemic myocardium and enhance the washout of its noxious metabolites. It has also been shown to increase collateral blood flow to the ischemic area (14) , probably secondary to a decrease in myocardial edema.
Our initial observations on the effectiveness of H in limiting myocardial infarct size in this animal model (9) have been extended in the present study to include a large number of animals studied histologically 21 days after occlusion as well as two further groups studied by the CK activity method at this time. Also, in the present study the amount of myocardium salvaged at 48 h and 21 days after occlusion has been quantified. The beneficial results obtained with this drug during the first 48 h exceeded those produced by the other interventions tested in this study. By the CK method there was _50% more residual myocardium in the H-treated than in controloccluded rats at the peak of the necrotic process (Table I) . After the infarct had healed, i.e., 3 wk after occlusion, the amount of preserved myocardium in the treated rats both by histology and by CK was still significantly greater than in the control-occluded rats, although this difference was less than at 48 h. Thus, although much of the early benefit derived from H administration appears to persist (Table II) , the loss of some of the early benefit may indicate that the drug does not protect the ischemic myocardium from all the factors that normally control its evolution to complete infarction.
CVF has also been shown by indirect techniques in the dog to limit myocardial necrosis 24 h after coronary occlusion (15) , but it has not been applied clinically. This substance depletes the third component of complement, thereby reducing the generation of leukotactic factors; it may act by reducing the myocardial injury that results from the release of lysosomal enzymes from infiltrating polymorphonuclear leukocytes and by reducing the capillary permeability and the injury to cell membranes which follow activation of the complement system. The present study extends previous observations by showing that the ischemic myocardium salvaged shortly after coronary occlusion by a single dose of CVF remains viable for a prolonged period.
Considerable controversy has surrounded the possible effects of glucocorticoids on infarct size. Pharmacologic doses of HC have been shown to diminish myocardial necrosis in the dog for up to 24 h (16), whereas pharmacologic doses of MP have been shown to reduce infarct size in some studies (17) , but fail to do so in others (27) . The longer-term effects of these glucocorticoids in the dog are unknown. In man, nonpharmacologic doses of HC have not consistently influenced mortality after acute myocardial infarction (28, 29) . With the use of CK curve analysis, pharmacologic doses of MP have been reported by Morrison et al. (30) to decrease infarct size, whereas deMello et al. (31) have reported an increase in infarct size and mortality. Multiple doses of MP administered to patients with acute myocardial infarction have also been reported possibly to increase the incidence of ventricular rupture (32) . The mechanism by which glucocorticoids may benefit acutely ischemic myocardium remains conjectural. 1 hey may stabilize cell membranes, prevent or delay the release of lysosomal enzymes (33, 34) , stabilize the phagocytic vacuoles in infiltrating inflammatory cells, thereby reducing their heterolytic activity (16) , inhibit the generation of prostaglandins and thromboxanes (35) , exert other antiinflammatory actions, or increase collateral blood flow to the ischemic myocardium (36) .
When administered during the first 24 h after a skin incision, glucocorticoids interfere with wound healing (37) . Although the rat is particularly sensitive to the metabolic effects of steroids, it is no more sensitive to steroid-induced interference with healing than are other species (38) . Furthermore, in the dog, pharmaco-logic doses of NIP adversely affect the early healing phase of acuite myocardial infarction (39) , and in one patient receiving prolonged HC therapy after acute myocardial infaretion, the development of a ventricular aneurysm was associated with delayed myocardial healing (40) .
Multiple doses of MP (equivalent to a 20-fold greater glucocorticoid effect than that of the single dose of HC) resulted in thinniing of the infarcts, either because of the high dose or its prolonged administration. At the time of sacrifice these abnormally thin infarcts had already developed into ventricular aneurysmiis (Fig. 4) . In the MP x 4-treated rats, the distensioin of the infarct 3 wk after occlusion may give the false impression that myocardial necrosis has been more extensive than is actually the case, there simply being greater representation of the infarct as a percent of the left ventricular suirf'ace. This situation represents expansion of the infarct rather than extension or reinfarctioni on account of a truie increase in necrosis (41) .
Pretreatment with R has the theoretical attraction that the catecholamine-depleted i schemic myocardium (18) may benefit not only froml the inhibition of adrenergically mediated stimulation of myocardial oxygen consumption, as occurs with propranolol-induced beta blockade (4, 5, (42) (43) (44) (45) , but also by the prevention of additioial mlyocardial d(amage by the local release of cateclholaminies from their stores in the cardiac adrenergic nerve endings as myocardial necrosis occurs. However, pretreatmnent with R resulted in only borderline long-termii salvage of ischemic myocardiuim and was less than that achieved by the other interventionis (Table II) .
In There are many obvious differences between this experimental model and the patient with acute myocardial infarction. The most important is the presence in nmost patients of diffuse atherosclerotic coronary artery disease, whereas in the rat only one coronary artery is occluded in a normal heart whose other coronary vessels are normal. Also, the oxygen consumlption of the rat heart, expressed on a weight basis, greatly exceeds that of the human heart. Therefore, myocardial necrosis would be expected to occur much more rapidly in the rat than in man after coronary occlusion. Therefore, it is not clear what time intervals between occlusion and interveintion would be comparable in these two species. However, we have noted in the dog that the effectiveness of H diminishes progressively as this interval lengthens; efficacy can still be demonstrated at 6 h but not at 9 h after coronary occlusion (13) . In addition, the pathological evolution of the infarct in the rat is telescoped in comparison to that in man; 48 h after coronary occlusion the infarct in the rat resembles one which is 4-days old in the human; the 21-day-old infarct in the rat is conmparable to a 42-day-old infaret in man (47) . However, despite the aforementioned differences between the rat and the human, the fundamental tissue changes after coronary occlusion are essentially identical in all mammalian species. Even though there may be quantitative differences between the effects of interventions in various species, we have noted no qualitative differences between the responses of the rat and dog. The principal advantage of this model is that it allows a relatively precise direct assessment of the effects of various interventions on infarct size.
The results of this study lend support to the suggestion that timely therapeutic interventions after coronary occlusioni in man may limit infarct size and thereby reduce the incidence of myocardial failure and its attendant mortality and morbidity. Of the various interventions tested in this study, the administration of H or CVF early after the occlusive event offers the greatest promise for further stuidy. The results of the preliminary clinical studies with H have been encouiraginig (11, 12) , but the definitive role of this agent in clinical practice needs to be determined in a much larger number of patients. CVF has not so far been giveni to patients; its role in clinlical practice is still to be determiined. Before glucocorticoids caii be recommended for further clinical trial, their lonigterm effects deserve fuirther stuidy so as to determinie the optimal dose anid frequency of administrationi that will achieve the mlaximnum myocardial salvage without causing thinning anid distenisioni of the infarcted tisstue during healing (48) . It is possible that, as in the experimental animal, the adminiistrationi of a sinigle dose will reduce myocardial damage, but that mulltiple doses are requiired in order to interfere withl the healing process. R might be usefull when administered prophylactically, bult in this study its beneficial effects were relatively' small. An importaint, unresolved question is whether combinations of these interventions, and others, suich as beta adrenergic blockers, which appear to act by fundamentally dissimiiilar mechanisms, will provide greater beniefit than single interventions.
